Clinical trial

Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants

NCT00899457

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2008-04-01

PhaseN/A

Study timeline

Study start (unknown)2008-04-01Date precision: month

Registry last updated2014-06-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Healthy, no Evidence of Diseaseunresolved

Lung Cancerunresolved

Interventions

proteomic profilingGENETIC

biologic sample preservation procedureOTHER

laboratory biomarker analysisOTHER

bronchoscopyPROCEDURE

Sponsors & collaborators

Vanderbilt-Ingram Cancer Centerlead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

NashvilleTennessee, United States3

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00899457 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.